Teva Pharmaceuticals v. Impax Labs

CourtSuperior Court of Pennsylvania
DecidedNovember 2, 2018
Docket2920 EDA 2017
StatusUnpublished

This text of Teva Pharmaceuticals v. Impax Labs (Teva Pharmaceuticals v. Impax Labs) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Teva Pharmaceuticals v. Impax Labs, (Pa. Ct. App. 2018).

Opinion

J-A08011-18

NON-PRECEDENTIAL DECISION – SEE SUPERIOR COURT I.O.P 65.37

TEVA PHARMACEUTICALS USA, INC. : IN THE SUPERIOR COURT OF AND TEVA PHARMACEUTICALS : PENNSYLVANIA CURACAO N.V. : : v. : : IMPAX LABORATORIES, INC., : : Appellant : No. 2920 EDA 2017

Appeal from the Order Dated August 23, 2017 In the Court of Common Pleas of Philadelphia County Civil Division at No(s): February Term, 2017, No. 03632

BEFORE: PANELLA, J., LAZARUS, J., and STRASSBURGER, J.*

CONCURRING AND DISSENTING MEMORANDUM BY STRASSBURGER,

J.: FILED NOVEMBER 02, 2018

I disagree with the learned Majority’s conclusion that the trial court’s

order is a collateral order. However, since a majority of the panel has held

that the order is collateral and thus appealable, I join the Majority in affirming

the order on the merits.

*Retired Senior Judge assigned to the Superior Court.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
Teva Pharmaceuticals v. Impax Labs, Counsel Stack Legal Research, https://law.counselstack.com/opinion/teva-pharmaceuticals-v-impax-labs-pasuperct-2018.